Acumen Pharmaceuticals Inc (ABOS) is near the top in its industry group according to InvestorsObserver. ABOS gets an overall rating of 63. That means it scores higher than 63 percent of stocks. Acumen Pharmaceuticals Inc gets a 73 rank in the Biotechnology industry. Biotechnology is number 23 out of 148 industries.
ABOS has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on ABOS!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Acumen Pharmaceuticals Inc Stock Today?
Acumen Pharmaceuticals Inc (ABOS) stock is trading at $6.12 as of 1:34 PM on Wednesday, May 10, a gain of $0.39, or 6.81% from the previous closing price of $5.73. The stock has traded between $5.48 and $6.33 so far today. Volume today is 186,711 compared to average volume of 210,246.
Click Here to get the full Stock Report for Acumen Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
